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maker to dual-chamber function, and no other abnormalities were
found.
It is unclear why our patient’s pacemaker detected an ERI
condition. Medtronic Thera platforms (including Prodigy, Preva,
Kappa 400, and Insynch 8040) can be especially sensitive to
electromagnetic interference signals entering via the telemetry coil,
which might account for our observation in this case. Although no
inappropriate ERI was found in the Martin et al. (1) series, which
included 12 of these platforms (but only one Thera device), no
thoracic spine MRI examinations were performed.
This outcome reminds us that significant pacemaker problems
might still occur during MRI, despite the experience of Martin et
al. (1). Although their report will likely permit better care of
pacemaker patients, the caveat that special care of these patients
appears necessary. We believe that recommendations from Martin
et al. (1) should be strengthened. Rather than simply available, a
physician who is “facile in the ways of pacemaker programming”
should be present to monitor the patient, as suggested by Gimbel
and Kanal (2). Additionally, the entire team caring for patients in
the MRI suite needs to be prepared to quickly and immediately
remove the patient from the MRI should a significant problem be
discovered.
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We thank Dr. Rozner and colleagues for their interest in our work
(1). They found that a Medtronic Thera DR 7960i pacemaker
demonstrated an elective replacement indicator upon interrogation
of the device immediately after magnetic resonance imaging
(MRI). This phenomenon is neither unexpected nor alarming.
Many pacemakers will respond with this warning after an exposure
to intense electromagnetic interference. Examples of this exposure
include direct current cardioversion, radiofrequency ablation, elec-
trocautery, and MRI. This response is unrelated to the battery
voltage or impedance but rather occurs because of a brief power
interruption. Magnetic resonance imaging can cause this behavior
when the telemetry coil or leads themselves are driven by the
radiofrequency output of the MRI, which can result in a parasitic
capacitance for brief instances. The solution, when this occurs, is
to reset the pulse generator. Newer pacemakers are more resistant
to such interference but also can demonstrate this problem.
With respect to their comments, several observations are rele-
vant. The statement that a “pacemaker-facile physician” be present
rather than available is consistent with our practice and our
recommendations. During all MRI examinations involving pace-
maker and implantable-cardiovertor defibrillator patients at Okla-
homa Heart Institute, an electrophysiologist is present and observ-
ing all available data from the start of the scan through completion
of the post exam interrogation. We concur wholeheartedly that
this extra step is mandatory to the performance of these studies.
Since the publication of our article (1), we have had the
opportunity to expand our pacemaker/MRI database to include a
total of 87 patients with 156 leads. We have continued to observe
similar but subtle threshold changes in a portion of leads subjected
to the levels of electromagnetic interference found at 1.5-T, but
none of these threshold changes have been beyond the safe
programming limits of the pulse generators.
We stand by our original conclusions. Performance of MRI in
appropriately selected, nonpacemaker-dependent patients can be
accomplished with an acceptable safety profile. Precautions must
include continuous monitoring of the patient with ECG and
intermittent voice contact, resuscitation equipment on standby,
adequate personnel to move and resuscitate the patient should the
need arise, and the presence of a person facile in pacemaker
interrogation and programming.
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Figure 2. Battery and lead data obtained immediately after magnetic
resonance imaging. Despite acceptable voltage and impedance, the pace-
maker shows “replace pacemaker,” rather than “OK,” for battery status.
Thus, the pacemaker changed from DDD pacing (lower rate 60, upper
tracking rate 135 beats/min) to VVI at 65 beats/min. For this pacemaker,
replacement is not needed until battery voltage is less than 2.62 volts with
impedance 3,000 ohms.
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